CERS Cerus Corp

Cerus Corp is a biomedical products company. It is engaged in developing and commercializing the INTERCEPT Blood System to enhance blood safety.

$5.24  -0.05 (-0.95%)
As of 07/01/2022 10:33:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/12/2001
Outstanding shares:  176,898,227
Average volume:  1,654,549
Market cap:   $944,636,532
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2222471
Valuation   (See tab for details)
PE ratio:   -19.02
PB ratio:   11.78
PS ratio:   5.46
Return on equity:   -61.96%
Net income %:   -28.44%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy